1. Development and validation of a plasma-based melanoma biomarker suitable for clinical use. British Journal of Cancer, 2018. 118(6): p. 857-866.
  2. A plasma microRNA biomarker of melanoma as a personalised assessment of treatment response. Melanoma Res, 2019. 29(1): p. 19-22.
  3. Characterisation and validation of Mel38; A multi-tissue microRNA signature of cutaneous melanoma. PLoS One, 2019. 14(2): p. e0211504.
  4. Translation of a circulating microRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision. Biomarkers In Medicine, 2021.